Results 221 to 230 of about 12,689 (257)
Some of the next articles are maybe not open access.
Problems with Interval Estimates of the Incremental Cost—Effectiveness Ratio
Medical Decision Making, 1999The defining feature of a confidence interval is that it has a fixed minimum probability of covering the true value of the parameter being estimated, whatever the value of the parameter. The authors demonstrate by simulation that some recently proposed meth ods for interval estimation of the incremental cost—effectiveness ratio (ICER) either do not ...
D F, Heitjan, A J, Moskowitz, W, Whang
openaire +2 more sources
Favorable incremental cost-effectiveness ratio for lung cancer screening in Italy
Lung Cancer, 2020Lung cancer detection by low-dose computed tomographic screening reduces mortality. However, it is essential to assess cost-effectiveness. We present a cost-effectiveness analysis of screening in Italians at high risk of lung cancer, from the point of view of the Italian tax-payer.We used a decision model to estimate the cost-effectiveness of annual ...
Giulia Veronesi +9 more
openaire +4 more sources
UNCERTAINTY OF INCREMENTAL COST-EFFECTIVENESS RATIOS
International Journal of Technology Assessment in Health Care, 1999Objective: To compare different methods to estimate the confidence interval of the incremental cost-effectiveness ratio (ICER).Methods: The adequacy of Fieller intervals and three methods for calculating bootstrap intervals are compared based on a simulation of 10,000 trials, using data from one trial.Results: Both Fieller and bootstrap methods lead
Severens, J.L. +2 more
openaire +3 more sources
On Estimating Medical Cost and Incremental Cost-Effectiveness Ratios with Censored Data
Biometrics, 2001Medical cost estimation is very important to health care organizations and health policy makers. We consider cost-effectiveness analysis for competing treatments in a staggered-entry, survival-analysis-based clinical trial. We propose a method for estimating mean medical cost over patients in such settings.
Zhao, Hongwei, Tian, Lili
openaire +2 more sources
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System
PharmacoEconomics, 2017Spending on new healthcare technologies increases net population health when the benefits of a new technology are greater than their opportunity costs-the benefits of the best alternative use of the additional resources required to fund a new technology.The objective of this study was to estimate the expected incremental cost per quality-adjusted life ...
Laura Catherine Edney +3 more
openaire +3 more sources
The precision of regression-type estimator for incremental cost–effectiveness ratio
Journal of Statistical Computation and Simulation, 2012The estimation of incremental cost–effectiveness ratio (ICER) has received increasing attention recently. It is expressed in terms of the ratio of the change in costs of a therapeutic intervention to the change in the effects of the intervention. Despite the intuitive interpretation of ICER as an additional cost per additional benefit unit, it is a ...
Chien-Hua Wu, Shu-Mei Wan
openaire +1 more source
International Journal of Technology Assessment in Health Care, 2018
Introduction:Current practice in cost-effectiveness analysis (CEA) involves the estimation of the incremental cost-effectiveness ratio (ICER) between a new intervention and one alternative comparator reflecting the standard of care. As this focuses on pairwise comparisons, rather than considering the whole range of available alternatives at any given ...
Stefano Lucherini +2 more
openaire +1 more source
Introduction:Current practice in cost-effectiveness analysis (CEA) involves the estimation of the incremental cost-effectiveness ratio (ICER) between a new intervention and one alternative comparator reflecting the standard of care. As this focuses on pairwise comparisons, rather than considering the whole range of available alternatives at any given ...
Stefano Lucherini +2 more
openaire +1 more source
Incremental cost-effectiveness ratio (ICER)
Abstract The incremental cost-effectiveness ratio (ICER) is an analysis used to summarize the cost-effectiveness of a healthcare intervention. An overview of the ICER principles is followed by a description of ICER thresholds and the approach to calculating ICERs.Phil Ambery +2 more
openaire +1 more source
Journal of Clinical Oncology, 2015
6621 Background: Cost effectiveness of predictive biomarkers is currently assessed by Markov Chain (MC) simulations, requiring resources and expertise.
Anton Safonov +6 more
openaire +1 more source
6621 Background: Cost effectiveness of predictive biomarkers is currently assessed by Markov Chain (MC) simulations, requiring resources and expertise.
Anton Safonov +6 more
openaire +1 more source
Heart, 2017
The article by Wouters and colleagues1 presents an exhaustive overview on how quality-adjusted life years (QALYs) can be used in cost-effectiveness analysis. In this framework, the authors also mention the incremental cost-effectiveness ratio (ICER), which is the parameter typically used to express the results of a cost-effectiveness study. The article,
Andrea, Messori, Sabrina, Trippoli
openaire +2 more sources
The article by Wouters and colleagues1 presents an exhaustive overview on how quality-adjusted life years (QALYs) can be used in cost-effectiveness analysis. In this framework, the authors also mention the incremental cost-effectiveness ratio (ICER), which is the parameter typically used to express the results of a cost-effectiveness study. The article,
Andrea, Messori, Sabrina, Trippoli
openaire +2 more sources